Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
4.180
-0.050 (-1.18%)
At close: Mar 6, 2026, 4:00 PM EST
4.990
+0.810 (19.38%)
After-hours: Mar 6, 2026, 7:59 PM EST
Lisata Therapeutics Market Cap
Lisata Therapeutics has a market cap or net worth of $36.87 million as of March 6, 2026. Its market cap has increased by 71.49% in one year.
Market Cap
36.87M
Enterprise Value
17.87M
1-Year Change
71.49%
Ranking
Category
Stock Price
$4.18
Market Cap Chart
Since August 9, 2007, Lisata Therapeutics's market cap has increased from $11.90M to $36.87M, an increase of 209.84%. That is a compound annual growth rate of 6.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 36.90M | 125.00% |
| Dec 31, 2025 | 16.40M | -34.40% |
| Dec 31, 2024 | 25.00M | 12.61% |
| Dec 29, 2023 | 22.20M | 11.56% |
| Dec 30, 2022 | 19.90M | -60.44% |
| Dec 31, 2021 | 50.30M | 81.59% |
| Dec 31, 2020 | 27.70M | 6.13% |
| Dec 31, 2019 | 26.10M | -25.43% |
| Dec 31, 2018 | 35.00M | 5.42% |
| Dec 29, 2017 | 33.20M | 43.72% |
| Dec 30, 2016 | 23.10M | -61.37% |
| Dec 31, 2015 | 59.80M | -55.61% |
| Dec 31, 2014 | 134.70M | -27.23% |
| Dec 31, 2013 | 185.10M | 93.62% |
| Dec 31, 2012 | 95.60M | 74.77% |
| Dec 30, 2011 | 54.70M | -32.64% |
| Dec 31, 2010 | 81.20M | 43.46% |
| Dec 31, 2009 | 56.60M | 1,564.71% |
| Dec 31, 2008 | 3.40M | -46.03% |
| Dec 31, 2007 | 6.30M | -47.06% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xilio Therapeutics | 38.93M |
| Jasper Therapeutics | 38.62M |
| Sensei Biotherapeutics | 37.96M |
| CervoMed | 37.94M |
| Actinium Pharmaceuticals | 37.44M |
| Atara Biotherapeutics | 37.28M |
| Tvardi Therapeutics | 36.87M |
| PDS Biotechnology | 36.61M |